Techsomed Ltd., a pioneer in medical software focusing on enhancing the clinical impact of ablation therapy, has announced that it has secured 510(k) clearance from the USA Food and Drug Administration (FDA) for its software, VisAble.IO. This software is designed to aid physicians in planning liver ablation procedures and verifying ablation zones, aiming to enhance treatment accuracy. Ablation Therapy, a favored minimally invasive treatment, uses extreme temperatures to eliminate abnormal tissue. The VisAble.IO software is a component of Techsomed’s comprehensive BioTrace solution, an AI-powered system for Image Guided Ablation Therapy. This system employs AI technology to utilize standard imaging techniques,…
Author: Abhay Panchal
Fecal immunochemical test (FIT)-based screenings have proven effective in detecting early-stage colorectal cancer (CRC) during both initial and subsequent screenings. Research data indicates that CRCs identified through FIT screenings are more frequently diagnosed at stages I to II (66%-71%) compared to CRCs detected clinically (40%-57%). Arthur I. Kooyker, MD, PhD, from the department of public health at Erasmus University Medical Center, and his team utilized data from a Dutch CRC screening program, examining over 266,434 individuals. The results showed that 66.5% of CRCs were diagnosed at stages I to II during the first screening and 67.7% during the second screening.…
A recent clinical trial has indicated that using resistant starch as a microbiota-directed dietary supplement could be a promising intervention for patients with non-alcoholic fatty liver disease (NAFLD). The study, which spanned four months, compared the outcomes of NAFLD patients on a resistant starch diet to a control group. The results revealed a 5.89% net absolute change in intrahepatic triglyceride content (IHTC) in the resistant starch group compared to the control group after adjusting for weight loss, equating to a relative change of 24.30%. Huating Li from Shanghai Sixth People’s Hospital emphasized the effectiveness, affordability, and sustainability of this intervention,…
The Centers for Medicare & Medicaid Services (CMS) has introduced a significant initiative to evaluate a state’s capability to enhance the overall health care management of its residents. The program, named the States Advancing All-Payer Health Equity Approaches and Development Model (or “States Advancing AHEAD” or “AHEAD Model”), is designed to more effectively tackle chronic illnesses, behavioral health issues, and other medical conditions. With the AHEAD Model, states that participate will be better positioned to foster health equity, expand access to primary care services, establish health care spending on a more sustainable path, and reduce health care expenses for patients.…
East Alabama Health has announced the inauguration of the Gastroenterology Center of EAMC on September 5, 2023. This new center aims to offer specialized and comprehensive care for patients with digestive and gastrointestinal issues. Dr. J. Randall Newman, M.D., will be the primary physician at the clinic. Dr. Newman completed his undergraduate studies in molecular biology at Vanderbilt University and pursued his medical degree and residency at the University of Alabama at Birmingham. He was honored with the Osler Award for Excellence in Clinical Diagnosis by an Intern. Subsequently, he completed his fellowship in gastroenterology at Vanderbilt. Dr. Newman has…
Gastroenterology services provider Gastro Care Partners plans to implement ModMed’s gastroenterology-specific technology through its more than 45 providers across multiple ASCs and practices. Gastro Care chose ModMed to standardize its operations, make health staff become more efficient and give patients direct access to scheduling and medical records, according to a Sept. 7 news release from ModMed.
The U.S. is witnessing a decline in the number of primary-care physicians, with many Americans struggling to find a family doctor. A study reveals that while the overall cancer incidence has decreased, liver cancer rates have surged by 48% since 2000. This decline is attributed to various factors, including the financial challenges faced by primary-care doctors due to the U.S. health system’s payment structure, which often favors surgeries and procedures over preventive care. Many primary-care doctors, feeling undervalued and financially strained, have sold their practices to health systems or commercial management chains, leading to three-quarters of doctors becoming employees of…
The article delves into the potential of fecal microbiota transplantation (FMT) as a treatment for ulcerative colitis (UC). A comprehensive systematic review and meta-analysis of randomized controlled trials were conducted to assess the efficacy and safety of FMT for UC. The research incorporated data from 13 randomized controlled trials involving 580 patients. The findings revealed that the FMT group had a significantly higher rate of clinical remission compared to the control group. Furthermore, endoscopic remission was also better in the FMT group. Importantly, there were no significant differences in the incidence of adverse reactions between the two groups. The study…
A comprehensive review and meta-analysis of 25 studies, involving approximately 30,000 adults, revealed that behavioral interventions can significantly enhance colonoscopy screening rates. The interventions, which included methods like patient navigation, informational brochures, and primary care provider counseling, were found to increase colonoscopy screening completion by 54% compared to standard care. Among these, patient navigation and multi-component interventions were the most frequently studied and showed the highest effectiveness, with odds ratios of 1.78 and 1.84 respectively. The study, led by Stephanie Yakoubovitch, MD, from Florida Atlantic University, emphasizes the importance of adopting behavioral interventions in clinical practice to improve screening rates.…
While the overall incidence of cancer in the U.S. has decreased, liver cancer has seen a 48% increase since 2000. A recent study, published in Clinical Gastroenterology and Hepatology, delves into the racial and ethnic differences in liver cancer trends. The study, led by Paulo Pinheiro, MD, PhD, from the Sylvester Comprehensive Cancer Center in Miami, found that while liver cancer due to hepatitis C has declined since 2015, cases from fatty-liver disease have increased, reflecting the rise in obesity and diabetes. The research emphasized that race, birthplace, and socioeconomic factors play a significant role in liver cancer causes. For…